PHD1 Antikörper (AA 167-407)
Kurzübersicht für PHD1 Antikörper (AA 167-407) (ABIN7569109)
Target
Alle PHD1 (EGLN2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 167-407
-
Verwendungszweck
- Anti-Human EGLN2/EIT6 Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human EGLN2/EIT6 (Glu167-Thr407).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- PHD1 (EGLN2) (Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2))
-
Andere Bezeichnung
- EGLN2
-
Hintergrund
- Estrogen-induced tag 6, EIT-6, HIF-prolyl hydroxylase 1, HIF-PH1, HPH-3, HPH-1, EIT6, PHD1, Prolyl hydroxylase domain-containing protein 1, Egl nine homolog 2, Prolyl hydroxylase EGLN2, Hypoxia-inducible factor prolyl hydroxylase 1, EGLN2
-
UniProt
- Q96KS0
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Cell RedoxHomeostasis
Target
-